Back to calendar
Coherus Oncology, Inc. (CHRS) Earnings
CHRS reports earnings on Wednesday, August 5, 2026
earnings report
August 5, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.24
Actual EPS: $-0.27
EPS surprise: -2.53%
Company overview
Market Cap$216.7M
PriceUSD 1.41
EPS (TTM)-1.25
52-week high2.62
52-week low0.81
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees147